Claro Advisors LLC Decreases Stake in CVS Health Co. (NYSE:CVS)

Claro Advisors LLC trimmed its position in shares of CVS Health Co. (NYSE:CVS) by 59.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,851 shares of the pharmacy operator’s stock after selling 7,173 shares during the period. Claro Advisors LLC’s holdings in CVS Health were worth $218,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. acquired a new position in shares of CVS Health during the 3rd quarter worth about $25,000. Ridgewood Investments LLC boosted its holdings in CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares in the last quarter. Livelsberger Financial Advisory purchased a new position in CVS Health in the third quarter valued at approximately $31,000. Legacy Investment Solutions LLC acquired a new stake in CVS Health during the third quarter worth approximately $31,000. Finally, Reston Wealth Management LLC acquired a new position in shares of CVS Health in the 3rd quarter valued at $32,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on CVS shares. Piper Sandler reduced their price target on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research report on Monday, November 25th. Royal Bank of Canada decreased their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $62.00 price target on shares of CVS Health in a research report on Tuesday, October 1st. UBS Group increased their price objective on CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a report on Thursday, November 7th. Finally, Barclays reduced their price target on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. One research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and an average target price of $68.71.

CVS Health Stock Performance

Shares of CVS stock opened at $52.15 on Thursday. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75. The company has a market cap of $65.63 billion, a price-to-earnings ratio of 13.24, a price-to-earnings-growth ratio of 0.85 and a beta of 0.59. The stock has a 50 day simple moving average of $51.68 and a 200-day simple moving average of $56.44.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the company earned $2.21 earnings per share. On average, equities analysts forecast that CVS Health Co. will post 5.32 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 5.10%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.